Start with filings
SEC filings provide the strongest basis for financial, listing and corporate-risk statements.
Independent academic projectNot an official Nemaura Medical website
Research · Evidence & sources
Read the company story with the dates attached.
This project distinguishes audited filings, company statements, regulatory reporting and historical professional profiles.
⌁
METHOD
How the profile was assembled.
Date every role
Leadership titles from older profiles are presented as historical or previously reported.
Separate approval
Regulatory status is described jurisdiction by jurisdiction rather than generalized globally.
Flag company claims
Pilots, orders and forecasts are not treated as completed revenue or guaranteed outcomes.
PRIMARY & SUPPORTING SOURCES
Documents used in this project.
01
SEC · FY2023 Form 10-KBusiness, products, audited financial statements, risks and operations
↗02SEC · January 2024 listing updateNasdaq delisting decision and OTC transition
↗03SEC · June 2024 information statementCorporate information and chief executive confirmation
↗04SFDA approval announcement · August 2023Saudi approval and product summary
↗05SEC exhibit · Provisional MENA orderLicensee relationship and order conditions
↗06UK Companies House · Nemaura Pharma LimitedRelated entity record and current company status
↗07SEC EDGAR · Nemaura Medical company recordSearchable corporate filing history
↗08Nemaura Medical · Official websiteCompany product, news and investor information
↗FRESHNESS NOTE
What should be rechecked?
Leadership & staff
Verify executives, directors and employee counts against the newest filing. LinkedIn and company profiles are useful leads, not complete staff directories.
FDA status
Do not infer approval from a proposed or submitted regulatory pathway.
Financials & trading
The audited figures shown are FY2023. Check SEC EDGAR and OTC Markets before describing financial or market data as current.
Product availability
Availability, labeling and approved use may differ by country. Company releases should be separated from regulator records.
Independent educational project
This website is not affiliated with Nemaura Medical Inc. and does not provide medical or investment advice.